Mycobacterium bovis bacillus calmette-guerin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection

Vaccine

Volumn 19, Issue 7-8, 2000, Pages 779-787

  Matsumoto, Sohkichi ^a   Yukitake, Hideharu ^a   Kanbara, Hiroji ^a   Yamada, Hiroshi ^b   Kitamura, Akira ^a   Yamada, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adjuvant; Malaria vaccine; Mycobacteria

Indexed keywords

IMMUNOGLOBULIN G2A; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALARIA; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PARASITOSIS; PLASMODIUM YOELII; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, PROTOZOAN; BCG VACCINE; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; KINETICS; MALARIA; MICE; MICE, INBRED A; MICE, INBRED ICR; NITRIC OXIDE; PLASMODIUM YOELII; SPLEEN; TH1 CELLS;

EID: 0034703810     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00257-7     Document Type: Article

References (37)

1. Functional diversity of helper T lymphocytes
2. Immunity to intracellular bacteria
3. T cell response to Mycobacterium tuberculosis
4. Modulation of fibronectin-mediated bacillus calmette-guerin attachment to murine bladder mucosa by drugs influencing the coagulation pathways
5. Characterization of the internalization of bacillus calmette-guerin by human bladder tumor cells
6. The inverse association between tuberculin responses and atopic disorder
7. Infection of mice with Mycobacterium bovis-bacillus calmette-guerin (BCG) suppresses allergen-induced airway eosinophilia
8. Protection of mice against Babesia and Plasmodium with BCG
9. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation
10. Malaria vaccines: multiple targets
11. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum
12. Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine
13. Recombinant Mycobacterium bovis bacillus calmette-guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon-γ and parasite-specific antibodies
14. Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1
15. Organization of rRNA genes in Mycobacterium bovis BCG
16. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
17. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
18. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
19. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism
20. The role of TH1 and TH2 cells in a rodent malaria infection
21. A Th1-associated increase in tumor necrosis factor-α expression in the spleen correlates with resistance to blood-stage malaria in mice
22. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection
23. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice
24. Passive immunization against murine malaria with an IgG3 monoclonal antibody
25. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model
26. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants
27. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii
28. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice
29. Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA)
30. Demonstration of a lipopolysaccharide-induced cytostatic effect on malarial parasites
31. Possible importance of macrophage-derived mediators in acute malaria
32. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes
33. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity
34. Functional characterization of the antibody-mediated protection against blood stages of Plasmodium falciparum in the monkey Saimiri sciureus
35. Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass
36. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria